# GTA-MEG as a Biomarker for Cognition in MS

> **NCT02851342** · — · COMPLETED · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 159 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02851342
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2018-01
- **Final completion:** 2019-01
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2020-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02851342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02851342, "GTA-MEG as a Biomarker for Cognition in MS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02851342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*